Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJLEN.L Regulatory News (JLEN)

  • There is currently no data for JLEN

Acquisition

1 Aug 2022 07:01

RNS Number : 3477U
JLEN Environmental Assets Group Ltd
01 August 2022
 

1 August 2022

 

JLEN Environmental Assets Group Limited

("JLEN" or the "Company")

 

Investment in a controlled environment aquaculture project

JLEN, the listed environmental infrastructure fund, is pleased to announce that it has reached financial close on a minority equity investment in a controlled environment aquaculture project. 

The equity investment will be made alongside other Foresight funds, as well as the developer and operator of the facility, Hima Seafood AS. JLEN's total investment is expected to be up to approximately £40m over the next three to four years.

The project consists of a land-based aquaculture facility to be built in Rjukan, Norway, and will use established recirculating aquaculture system ("RAS") technology. It is expected that partial operations will commence in 2024 with full operations expected in 2025, following which, the facility is forecasted to produce approximately 8,000 tonnes of trout annually. This will be sold to European and international salmonid markets via an offtake agreement with an established Norwegian seafood distribution company with global reach.

Driven by a growing global population and an expanding middle class, the world faces an increasing demand for quality protein amid limited resources of usable land and water. Recent data shows that 34.8%1 of global animal protein production comes from fish and seafood sources and the fish and seafood market grew between 4% - 8% annually in the ten-year period to 20191. 

Global demand for animal protein is projected to double by 20502. Fish, including salmonids such as salmon and trout, is considered one of the most efficient sources of high-quality animal protein due to the rate at which it converts feed into edible mass, its high protein retention and high rate of edible meat per kilogram, as well as various nutritional benefits. Land-based aquaculture, such as the RAS based facility to be built in Rjukan, can provide a range of benefits compared with alternative methods of aquaculture such as improved fish mortality rates, less local environmental degradation and a lower use of antibiotics and other chemicals to control disease and parasites.

 

Richard Ramsay, Senior Independent Director of JLEN, said:

 

"We are pleased to make our first investment into land-based aquaculture, contributing to the sustainable supply of trout to meet rising consumer demand. We consider that this investment will deliver environmental benefits to the food system and offer a product to suit today's consumer needs."

1) Source: United Nations FAO, FAOSTAT Statistical Database

2) Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532560/#B2-foods-06-00053

 

For further information and enquiries, please contact:

 

Foresight Group

Chris Tanner

Chris Holmes

 

+44 (0)20 3667 8100

Winterflood Investment Trusts

Neil Langford

Chris Mills

 

+44 (0)20 3100 0000

SEC Newgate (For media enquiries)

Elisabeth Cowell

+44 (0)20 3757 6882

jlen@secnewgate.co.uk

 

Sanne Fund Services (Guernsey) Limited

Matt Falla

Gemma Woods

+44 (0)14 8175 5530

 

About JLEN

JLEN's investment policy is to invest in a diversified portfolio of Environmental Infrastructure. Environmental Infrastructure is defined by the Company as infrastructure assets, projects and asset-backed businesses that utilise natural or waste resources or support more environmentally friendly approaches to economic activity, support the transition to a low carbon economy or which mitigate the effects of climate change. Such investments will typically feature one or more of the following characteristics:

- long-term, predictable cash flows, which may be wholly or partially inflation-linked cash flows;

- long-term contracts or stable and well-proven regulatory and legal frameworks; or

- well-established technologies, and demonstrable operational performance.

JLEN's aim is to provide investors with a sustainable, progressive dividend per share, paid quarterly and to preserve the capital value of the portfolio over the long term on a real basis. The target dividend for the year to 31 March 2023 is 7.14 pence per share1. The dividend is payable quarterly.

Further details of the Company can be found on its website www.jlen.com

LEI: 213800JWJN54TFBMBI68

(1) These are targets only and not profit forecasts. There can be no assurance that these targets will be met or that the Company will make any distributions at all.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRBMFTMTAJBIT
Date   Source Headline
23rd Mar 20217:00 amRNSAcquisition
8th Mar 202111:22 amRNSResult of EGM
3rd Mar 20217:00 amRNSAcquisition
24th Feb 20217:00 amRNSNotice of Capital Markets Day
16th Feb 202112:28 pmRNSUpdate research from QuotedData
16th Feb 20217:00 amRNSPublication of Shareholder Circular, Notice of EGM
15th Feb 202110:09 amRNSDirector Declaration
12th Feb 20217:00 amRNSNet Asset Value and Dividend Declaration
4th Feb 20217:00 amRNSAcquisition
4th Dec 20201:17 pmRNSAcquisition
26th Nov 20207:00 amRNSHalf-year Results, Dividend Declaration
27th Oct 20207:00 amRNSNotice of Results
18th Sep 20207:00 amRNSAcquisition
15th Sep 20206:00 pmRNSHolding(s) in Company
3rd Sep 20202:22 pmRNSResult of AGM and Directorate Change
18th Aug 20207:00 amRNSNet Asset Value and Dividend Declaration
7th Aug 20204:38 pmRNSDirector Declaration
30th Jun 20205:12 pmRNSNotice of AGM
11th Jun 20204:25 pmRNSDirectorate Change
11th Jun 20207:00 amRNSAnnual Financial Report
28th May 20207:00 amRNSNet Asset Value and Dividend
14th May 202011:16 amRNSUpdate research from QuotedData
7th May 20207:00 amRNSNotice of Results
2nd Apr 20207:00 amRNSAcquisition
1st Apr 20208:06 amRNSTotal Voting Rights
26th Mar 20207:00 amRNSCOVID-19 Update
5th Mar 20202:11 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSAppointment of Non-Executive Director
27th Feb 20207:00 amRNSResult of Placing
13th Feb 20209:33 amRNSHolding(s) in Company
11th Feb 20207:02 amRNSRestructuring of Investment Advisory Arrangements
11th Feb 20207:00 amRNSProposed Placing
29th Jan 20207:00 amRNSNet Asset Value and Dividend Declaration
28th Jan 20207:00 amRNSPartnership Commitment
13th Dec 20197:00 amRNSAcquisition
4th Dec 20195:44 pmRNSHolding(s) in Company
21st Nov 20197:00 amRNSHalf-year Results, Dividend Declaration
17th Oct 20197:00 amRNSNotice of Results
10th Sep 20197:45 amRNSUpdate research from QuotedData
29th Aug 20192:36 pmRNSHolding(s) in Company
29th Aug 20197:00 amRNSAcquisition
15th Aug 20197:00 amRNSNet Asset Value and Dividend Declaration
14th Aug 20194:22 pmRNSResult of AGM & Change of Company Name
19th Jul 20197:00 amRNSAcquisition
5th Jul 20195:05 pmRNSNotice of AGM
1st Jul 20192:51 pmRNSChange of Adviser
13th Jun 20197:00 amRNSAnnual Financial Report
5th Jun 20197:00 amRNSProposed Change of Investment Adviser
30th May 20197:00 amRNSNet Asset Value and Dividend Declaration
20th May 20197:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.